News

Latest news

Hide mandatory notifications of trade

Bionor Pharma Presenting Q3 2013 Interim Report by Webcast Friday 8 November at 8.30 am CET

Bionor Pharma ASA (OSE:BIONOR) will announce its Q3 2013 interim report Friday 8 November 2013 at 8.30.

(Oslo, 1 November 2013) We are pleased to invite you to join in on our international webcast (and teleconference) for analysts, investors and other stakeholders at 08.30 CET to discuss the progress and results with Bionor Pharma’s senior management.

Webcast
A live audio webcast of the call will be available together with the slide presentation at http://www.media-server.com/m/p/zovaz8yn

Call numbers
For those without a computer available, and for ability to ask questions at the end of the presentation, use the following number: +44(0)20 3427 1910 (UK), +1212 444 0412 (US), +47 2316 2729 (Norway), +45 32 71 16 58 (Denmark) or +46(0)8 5033 6538 (Sweden), and request to be connected to the Bionor Pharma’s teleconference (confirmation code 1621620). Please use a quiet room.

Schedule for the webcast /teleconference 8 November (CET time)
08.25  -Log in to the webcast-link, and/or call the above number
08.30  -Review of results by Bionor Pharma’s senior management
           -Questions and answers

One week replay
There will be a replay facility available for one week (from one hour following the teleconference). The number to dial is +44(0)20 3427 0598 (UK), +1 347 366 9565 (US), +47 2100 0498 (Norway), +45 32 71 09 13 (Denmark) or +46(0)8 5051 3897 (Sweden), access code for all numbers is 1621620#.

Information about Bionor Pharma is available at www.bionorpharma.com.

Bionor Pharma ASA
Synne Røine
CFO
Tel +47 99 22 98 92